Matinas Biopharma (MTNB) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PRF Technologies is the larger company by market cap ($3.0 million vs $2.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MTNB | PRFX |
|---|---|---|
| Share price | $2.83 | $0.8587 |
| Market cap | $2.77M | $3.00M |
| 1-day change | +2.17% | -2.16% |
| EPS (TTM) | $-17.55 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $7.95 |
| 52-week low | $2.27 | $0.8511 |
| Distance from 52-week high | -90.22% | -89.20% |
| Average volume | 405.99K | 298.86K |
| Shares outstanding | 979.52K | 3.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MTNB vs PRFX FAQ
Which is bigger, Matinas Biopharma or PRF Technologies?
PRF Technologies (PRFX) is larger, with a market capitalization of $3.00M compared with $2.77M for Matinas Biopharma (MTNB).
Are Matinas Biopharma and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.